GAUDIUMIVF NSE filing

Gaudium IVF: Regulation 74(5) Compliance Certificate for Q4 FY26 Issued

The RealCase readLow impact Neutral

Gaudium IVF and Women Health Limited received a compliance certificate for the quarter ended March 31, 2026. The Registrar and Transfer Agent confirmed that Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, is not applicable as all shares are in demat form.

Why it matters

This is a standard regulatory filing that confirms the company's compliance status regarding share dematerialization, which is a routine process and does not have a material impact on the company's business or financial performance.

The market read

The announcement is a routine compliance filing and does not contain any significant new information that would impact the company's stock price or business operations.

Gaudium IVF and Women Health Limited has submitted a compliance certificate for the quarter ended March 31, 2026, under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The company's Registrar and Transfer Agent, M/s. Bigshare Services Private Limited, confirmed that the said regulation is not applicable to Gaudium IVF.

This is because the entire holding of the company's shares is in demat form. Bigshare Services Private Limited also stated that they have not received any requests from any company members for the rematerialisation or dematerialisation of shares during the quarter ended March 31, 2026. The certificate was sent to BSE Limited and the National Stock Exchange of India Limited for their information and records.

Filing to action

What to do with a filing like this

Gaudium IVF and Women Health Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Gaudium IVF and Women Health Limited. Read the original for the full detail.

View original filing